FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917502711> ?p ?o ?g. }

• W2917502711 endingPage "1424" @default.
• W2917502711 startingPage "1413" @default.
• W2917502711 abstract "Evaluate abatacept retention over 2 years in the AbataCepT In rOutiNe clinical practice (ACTION) study. ACTION was an international, observational study of patients with moderate-to-severe rheumatoid arthritis (RA) who initiated intravenous abatacept. Crude abatacept retention rates over 2 years were estimated using Kaplan–Meier analyses in biologic-naive and -failure patients. Clinically relevant risk factors and significant prognostic factors for retention were evaluated using a Cox proportional hazards multivariable model. Overall, 2350/2364 enrolled patients were evaluable; 673 (28.6%) were biologic naive and 1677 (71.4%) had prior biologic failure (1 biologic, 728/1677 [43.4%]; ≥ 2 biologics, 949/1677 [56.6%]). Abatacept retention rate (95% confidence interval [CI]) at 2 years was 47.9% (45.7, 50.0): 54.5% (50.4, 58.3) for biologic-naive vs 45.2% (42.7, 47.7) for biologic-failure patients (log-rank P < 0.001). For patients with 1 and ≥ 2 prior biologic failures, respectively, retention rates (95% CI) were 50.2% (46.3, 53.9) vs 41.3% (38.0, 44.6; log-rank P < 0.001). Main reasons for discontinuation (biologic-naive vs biologic-failure, respectively) were lack of efficacy (61.4 vs 67.7%) and safety (21.3 vs 21.2%). Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) double positivity versus negativity were predictive of higher retention in both biologic-naive (hazard ratio [HR] [95% CI] 0.71 [0.53, 0.96]; P = 0.019) and biologic-failure patients (HR [95% CI] 0.76 [0.62, 0.94]; P = 0.035). Abatacept initiation as earlier vs later line of therapy in RA may achieve higher 2-year retention rates. RF and anti-CCP seropositivity could predict increased abatacept retention, irrespective of treatment line. NCT02109666" @default.
• W2917502711 created "2019-03-02" @default.
• W2917502711 creator A5002428943 @default.
• W2917502711 creator A5003774188 @default.
• W2917502711 creator A5005291921 @default.
• W2917502711 creator A5006533368 @default.
• W2917502711 creator A5015852574 @default.
• W2917502711 creator A5028181759 @default.
• W2917502711 creator A5036981064 @default.
• W2917502711 creator A5051196993 @default.
• W2917502711 creator A5066439668 @default.
• W2917502711 creator A5079831828 @default.
• W2917502711 creator A5084949464 @default.
• W2917502711 date "2019-02-21" @default.
• W2917502711 modified "2023-09-27" @default.
• W2917502711 title "Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study" @default.
• W2917502711 cites W1654800013 @default.
• W2917502711 cites W1660699958 @default.
• W2917502711 cites W1857270174 @default.
• W2917502711 cites W1985557489 @default.
• W2917502711 cites W2001917088 @default.
• W2917502711 cites W2056198413 @default.
• W2917502711 cites W2073831898 @default.
• W2917502711 cites W2074396393 @default.
• W2917502711 cites W2078595150 @default.
• W2917502711 cites W2103422055 @default.
• W2917502711 cites W2115018403 @default.
• W2917502711 cites W2118378094 @default.
• W2917502711 cites W2118463772 @default.
• W2917502711 cites W2120393706 @default.
• W2917502711 cites W2127696180 @default.
• W2917502711 cites W2139201413 @default.
• W2917502711 cites W2152348310 @default.
• W2917502711 cites W2152350812 @default.
• W2917502711 cites W2215521920 @default.
• W2917502711 cites W2255303688 @default.
• W2917502711 cites W2307567353 @default.
• W2917502711 cites W2331283547 @default.
• W2917502711 cites W2404262996 @default.
• W2917502711 cites W2411231953 @default.
• W2917502711 cites W2554087892 @default.
• W2917502711 cites W2588423852 @default.
• W2917502711 cites W2766047656 @default.
• W2917502711 cites W2778619403 @default.
• W2917502711 cites W2789297701 @default.
• W2917502711 cites W2971217817 @default.
• W2917502711 cites W4292528167 @default.
• W2917502711 cites W4295125684 @default.
• W2917502711 cites W2008276323 @default.
• W2917502711 doi "https://doi.org/10.1007/s10067-019-04449-w" @default.
• W2917502711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30790095" @default.
• W2917502711 hasPublicationYear "2019" @default.
• W2917502711 type Work @default.
• W2917502711 sameAs 2917502711 @default.
• W2917502711 citedByCount "17" @default.
• W2917502711 countsByYear W29175027112019 @default.
• W2917502711 countsByYear W29175027112020 @default.
• W2917502711 countsByYear W29175027112021 @default.
• W2917502711 countsByYear W29175027112022 @default.
• W2917502711 countsByYear W29175027112023 @default.
• W2917502711 crossrefType "journal-article" @default.
• W2917502711 hasAuthorship W2917502711A5002428943 @default.
• W2917502711 hasAuthorship W2917502711A5003774188 @default.
• W2917502711 hasAuthorship W2917502711A5005291921 @default.
• W2917502711 hasAuthorship W2917502711A5006533368 @default.
• W2917502711 hasAuthorship W2917502711A5015852574 @default.
• W2917502711 hasAuthorship W2917502711A5028181759 @default.
• W2917502711 hasAuthorship W2917502711A5036981064 @default.
• W2917502711 hasAuthorship W2917502711A5051196993 @default.
• W2917502711 hasAuthorship W2917502711A5066439668 @default.
• W2917502711 hasAuthorship W2917502711A5079831828 @default.
• W2917502711 hasAuthorship W2917502711A5084949464 @default.
• W2917502711 hasBestOaLocation W29175027111 @default.
• W2917502711 hasConcept C126322002 @default.
• W2917502711 hasConcept C198451711 @default.
• W2917502711 hasConcept C207103383 @default.
• W2917502711 hasConcept C2776232647 @default.
• W2917502711 hasConcept C2777575956 @default.
• W2917502711 hasConcept C2778715236 @default.
• W2917502711 hasConcept C2779338263 @default.
• W2917502711 hasConcept C2779605438 @default.
• W2917502711 hasConcept C2780653079 @default.
• W2917502711 hasConcept C38652104 @default.
• W2917502711 hasConcept C41008148 @default.
• W2917502711 hasConcept C44249647 @default.
• W2917502711 hasConcept C50382708 @default.
• W2917502711 hasConcept C71924100 @default.
• W2917502711 hasConcept C79736992 @default.
• W2917502711 hasConceptScore W2917502711C126322002 @default.
• W2917502711 hasConceptScore W2917502711C198451711 @default.
• W2917502711 hasConceptScore W2917502711C207103383 @default.
• W2917502711 hasConceptScore W2917502711C2776232647 @default.
• W2917502711 hasConceptScore W2917502711C2777575956 @default.
• W2917502711 hasConceptScore W2917502711C2778715236 @default.
• W2917502711 hasConceptScore W2917502711C2779338263 @default.
• W2917502711 hasConceptScore W2917502711C2779605438 @default.
• W2917502711 hasConceptScore W2917502711C2780653079 @default.
• W2917502711 hasConceptScore W2917502711C38652104 @default.

• next